Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma

Auris Nasus Larynx

Volumn 34, Issue 1, 2007, Pages 79-84

  Katori, Hideaki ^a,b   Nozawa, Akinori ^b   Tsukuda, Mamoru ^c  

^a YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Ki 67; Pleomorphic adenoma

Indexed keywords

CELL PROTEIN; CYCLOOXYGENASE 2; KI 67 ANTIGEN; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MALIGNANT TRANSFORMATION; MORPHOLOGY; OPTICAL DENSITY; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIALOADENITIS; STAINING; UNIVERSITY HOSPITAL;

ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PAROTID NEOPLASMS; SALIVARY GLAND NEOPLASMS;

EID: 33846369048     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2006.09.006     Document Type: Article

References (26)

1. Seifert G. WHO international histological classification of tumours. Histological typing of salivary gland tumours (2005), Springer-Verlag, Berlin p. 122-9
2. Harada H. Histomorphological investigation regarding to malignant transformation of pleomorphic adenoma (so-called malignant mixed tumor) of salivary gland origin: special reference to carcinoma. Kurume Med J 47 (2000) 307-323
3. Gnepp D.R. Malignant mixed tumors of the salivary glands. Pathol Ann 28 (1993) 279-328
4. Vane J. Towards a heller aspirin. Nature 307 (1994) 215-216
5. Thomas P., Doddoli C., and Lienne P. Changing patterns and surgical results in adenocarcinonia of (heoesophagus). Br J Surg 84 (1997) 119-125
6. Harrow D.C., Vaughan T.L., and Ilausten P.D. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Lpidemiol Biomark Prev 7 (1998) 97-102
7. Jones D.A., Carlton D.P., Melnlyre T.M., Zimmerman G.A., and Prescott S.M. Molecular cloning of human prostaglandin endoperoxide synthase type Il and demonstration of expression in response to cytokines 1. Biol Chem 268 (1993) 9049-9054
8. Coffey K.J., Hawkey C.J., and Damstrup L. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 94 (1997) 657-662
9. Tsujii M., and DuBois K.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthasis 2. Cell 83 (1995) 493-501
10. Jones M.K., Wang H., and Peskar H.M. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5 (1999) 1418-1423
11. Tsujii M., Kawano S., and DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94 (1997) 3336-3340
12. Ben-Av P., Crofford I.J., Wilder R.L., and HIa T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372 (1995) 83-87
13. Ooodwin J.S., and Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol 3 (1983) 295-315
14. Reddy B.S., Maruyama H., and Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a non-steroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res 47 (1987) 5340-5346
15. Giovanucci E., Egan K.M., and Hunter D.J. Aspirin and the risk of colorectal cancer in women. N Engl J Med 333 (1995) 609-614
16. DuBois R.N., Awad J., Morrow J., Roberts L.J., and Bishop II P.R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 93 (1994) 493-498
17. Gerdes J., Lemke H., and Baisch H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133 (1984) 1710-1715
18. Katori H., Nozawa A., and Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol 31 (2005) 905-911
19. Katori H., Nozawa A., and Tsukuda M. Increased expression of matrix metalloproteinase-2 and 9 and human papilloma virus infection are associated with malignant transformation of sinonasal inverted papilloma. J Surg Oncol 93 (2006) 80-85
20. Keshgegian A.A., and Cnaan A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-I. Am J Clin Pathol 104 (1995) 42-49
21. Katoh R., Bray C.E., and Suzuki K. Growth activity in hyperplastic and neoplastic human thyroid determined by un immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 26 (1995) 139-146
22. Lynch D.A., Clarke A.M., Jackson P., Axon A.T., Dixon M.P., and Quirke P. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol 47 (1994) 122-125
23. Ozaki O., Uo K., Mimura T., Sugino K., and Ito K. Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologie and immunohistochemical study. J Surg Oncol 70 (1999) 45-48
24. Sugitani I., Yanagisawa A., Shimizu A., Kato M., and Fujimoto Y. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22 (1998) 731-737
25. Zhu Q., Tipoe G.L., and White P.H. Proliferate activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland. Anal Quant Cytol Histol 21 (1999) 336-342
26. Morris C.D., Armstrong G.R., Biglcy G., Green H., and Attwood S.E. Cyclooxygenase-2 expression in the Barren's metaplasiadysplasia-adenocarcinoma sequence. Am J Gastroenterol 96 (2001) 990-996